Browsing: Lilly

Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly…

(Reuters) -Eli Lilly’s treatment for early Alzheimer’s is expected to be blocked for use by Britain’s National Health Service (NHS),…

Eli Lilly CEO David Ricks on Tuesday quantified how much less patients taking the company’s weight-loss drug Zepbound tend to…

We are selling 100 shares of Abbott Laboratories at roughly $110.84. Following the trade, Jim Cramer’s Charitable Trust will own…

(Updated – August 20, 2024 11:24 AM EDT) Investing.com — U.S. stock futures traded lower Tuesday, consolidating after recent strong…

Check out the companies making the biggest moves in premarket trading: Eli Lilly — Shares added 1.7% after a late-stage…

Eli Lilly — The drug maker’s stock surged 8% after the firm reported second-quarter earnings and revenue that blew past…

Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by…

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a…

By Maggie Fick and Patrick Wingrove LONDON/NEW YORK (Reuters) – As Eli Lilly (NYSE:)’s weight-loss drug Zepbound gains ground in…